Skip to main content
Erschienen in: Journal of Neurology 7/2012

01.07.2012 | Original Communication

Posterior reversible encephalopathy syndrome (PRES): electroencephalographic findings and seizure patterns

verfasst von: Oliver Kastrup, Markus Gerwig, Markus Frings, Hans-Christoph Diener

Erschienen in: Journal of Neurology | Ausgabe 7/2012

Einloggen, um Zugang zu erhalten

Abstract

To better describe seizure type, frequency, and electroencephalographic (EEG) findings in posterior reversible encephalopathy syndrome (PRES) and correlate these data with clinical and magnetic resonance imaging (MRI) data, we retrospectively assessed medical charts and EEG studies of patients with PRES treated between 2004 and 2011. Data collected included patients’ underlying pathology, lesion distribution by MRI, seizure type and frequency, EEG pathologic background activity, focal pathology, and epileptogenic activity. Thirty-eight of 49 adults with PRES suffered from seizures; 17 underwent EEG and were included in the analysis. Perpetuating factors were similar to those reported in the literature. In 15 of 17 patients, MRI showed widespread involvement rather than purely occipital lesions. Nine patients had subcortical and cortical involvement. Seizures were single short grand mal (GM) in 11, serial GM in 2, recurrent GM in 2, and additional focal seizures in 2. No seizures were noted beyond the first day. After discontinuation of antiepileptic medication, no patients experienced seizure recurrence during 6-month follow-up. EEG showed diffuse theta/delta slowing in 13 patients and epileptogenic activity with focal sharp-wave and periodic lateralizing epileptiform discharges in 2 patients. Seizures in PRES are most commonly single GM and are usually of limited duration. EEG shows variable theta/delta slowing. Focal EEG pathology is seen in patients with focal seizures. Seizures occur early after disease onset and terminate spontaneously or under therapy during the first 24 h. Seizure recurrence beyond 24 h and chronic epilepsy were not seen. Seizures in PRES are frequent but appear to be uncomplicated and do not herald worse prognosis. EEG is helpful in evaluating the degree of encephalopathy and monitoring epileptic activity. Long-term antiepileptic medication does not appear to be warranted.
Literatur
1.
Zurück zum Zitat Casey SO, Sampaio RC, Michel E, Truwit CL (2000) Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. Am J Neuroradiol 21:1199–1206PubMed Casey SO, Sampaio RC, Michel E, Truwit CL (2000) Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. Am J Neuroradiol 21:1199–1206PubMed
2.
Zurück zum Zitat Dillon WP, Rowley H (1998) The reversible posterior cerebral edema syndrome. Am J Neuroradiol 19:591–595PubMed Dillon WP, Rowley H (1998) The reversible posterior cerebral edema syndrome. Am J Neuroradiol 19:591–595PubMed
3.
Zurück zum Zitat Trullemans F, Grignard F, van Camp B, Schots R (2001) Clinical findings and magnetic resonance imaging in severe cyclosporine-related neurotoxicity after allogeneic bone marrow transplantation. Eur J Haematol 67:94–99 Trullemans F, Grignard F, van Camp B, Schots R (2001) Clinical findings and magnetic resonance imaging in severe cyclosporine-related neurotoxicity after allogeneic bone marrow transplantation. Eur J Haematol 67:94–99
4.
Zurück zum Zitat Kastrup O, Diener HC (1997) Granulocyte-stimulating factor filgrastim and molgramostim induced recurring encephalopathy and focal status epilepticus. J Neurol 244:274–275PubMedCrossRef Kastrup O, Diener HC (1997) Granulocyte-stimulating factor filgrastim and molgramostim induced recurring encephalopathy and focal status epilepticus. J Neurol 244:274–275PubMedCrossRef
5.
Zurück zum Zitat Kastrup O, Maschke M, Wanke I, Diener HC (2002) Posterior reversible encephalopathy syndrome due to severe hypercalcemia. J Neurol 249:1563–1566PubMedCrossRef Kastrup O, Maschke M, Wanke I, Diener HC (2002) Posterior reversible encephalopathy syndrome due to severe hypercalcemia. J Neurol 249:1563–1566PubMedCrossRef
6.
Zurück zum Zitat Hinchey J, Chaves C, Appignani B et al (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334:494–500PubMedCrossRef Hinchey J, Chaves C, Appignani B et al (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334:494–500PubMedCrossRef
7.
Zurück zum Zitat Obeid T, Shami A, Karsou S (2004) The role of seizures in reversible posterior leukoencephalopathy. Seizure 13:277–281PubMedCrossRef Obeid T, Shami A, Karsou S (2004) The role of seizures in reversible posterior leukoencephalopathy. Seizure 13:277–281PubMedCrossRef
8.
Zurück zum Zitat Roos KL, Tuite PJ, Below ME, Pascuzzi RM (1990) Reversible cortical blindness (Anton’s syndrome) associated with bilateral occipital EEG abnormalities. Clin Electroencephalogr 21:104–109PubMed Roos KL, Tuite PJ, Below ME, Pascuzzi RM (1990) Reversible cortical blindness (Anton’s syndrome) associated with bilateral occipital EEG abnormalities. Clin Electroencephalogr 21:104–109PubMed
9.
Zurück zum Zitat Grimbert P, Azema C, Pastural M et al (1999) Tacrolismus (FK506)-induced severe and late encephalopathy in a renal transplant recipient. Nephrol Dial Transplant 14:2489–2491PubMedCrossRef Grimbert P, Azema C, Pastural M et al (1999) Tacrolismus (FK506)-induced severe and late encephalopathy in a renal transplant recipient. Nephrol Dial Transplant 14:2489–2491PubMedCrossRef
10.
Zurück zum Zitat Parvex P, Piinsk M, Bell LE et al (2001) Reversible encephalopathy associated with tacrolimus in pediatric renal transplants. Pediatr Nephrol 16:537–542PubMedCrossRef Parvex P, Piinsk M, Bell LE et al (2001) Reversible encephalopathy associated with tacrolimus in pediatric renal transplants. Pediatr Nephrol 16:537–542PubMedCrossRef
11.
Zurück zum Zitat Bhatt A, Faroog MU, Bhatt S, Majid A, Kassab MY (2008) Periodic lateralized epileptiform discharges: an initial electrographic pattern in reversible posterior leukoencephalopathy syndrome. Neurol Neurochir Pol 42:55–59PubMed Bhatt A, Faroog MU, Bhatt S, Majid A, Kassab MY (2008) Periodic lateralized epileptiform discharges: an initial electrographic pattern in reversible posterior leukoencephalopathy syndrome. Neurol Neurochir Pol 42:55–59PubMed
12.
Zurück zum Zitat Kozak OS, Wijdicks EF, Manno EM, Miley J, Rabinstein AA (2007) Status epilepticus as initial manifestation of posterior reversible encephalopathy syndrome. Neurology 69:894–897 Kozak OS, Wijdicks EF, Manno EM, Miley J, Rabinstein AA (2007) Status epilepticus as initial manifestation of posterior reversible encephalopathy syndrome. Neurology 69:894–897
13.
Zurück zum Zitat Baldini M, Bartolini E, Gori S, Bonanni E, Cosottini M, Ludice A, Murri L (2010) Epilepsy after neuroimaging normalization in a woman with tacrolismus-related posterior reversible encephalopathy syndrome. Epilepsy Behav 17:558–560PubMedCrossRef Baldini M, Bartolini E, Gori S, Bonanni E, Cosottini M, Ludice A, Murri L (2010) Epilepsy after neuroimaging normalization in a woman with tacrolismus-related posterior reversible encephalopathy syndrome. Epilepsy Behav 17:558–560PubMedCrossRef
14.
Zurück zum Zitat Skiba V, Etienne M, Miller JA (2011) Development of chronic epilepsy after recurrent episodes of posterior reversible encephalopathy syndrome associated with periodic lateralized epileptiform discharges. Seizure 20:93–95PubMedCrossRef Skiba V, Etienne M, Miller JA (2011) Development of chronic epilepsy after recurrent episodes of posterior reversible encephalopathy syndrome associated with periodic lateralized epileptiform discharges. Seizure 20:93–95PubMedCrossRef
15.
Zurück zum Zitat Natsume J, Sofue A, Yamada A, Kato K (2006) Electroencephalographic (EEG) findings in posterior reversible encephalopathy associated with immunosuppressants. J Child Neurol 21:620PubMedCrossRef Natsume J, Sofue A, Yamada A, Kato K (2006) Electroencephalographic (EEG) findings in posterior reversible encephalopathy associated with immunosuppressants. J Child Neurol 21:620PubMedCrossRef
16.
Zurück zum Zitat Servillo G, Bifulco F, De Robertis E et al (2007) Posterior reversible encephalopathy syndrome in intensive care medicine. Intensive Care Med 33:230–236PubMedCrossRef Servillo G, Bifulco F, De Robertis E et al (2007) Posterior reversible encephalopathy syndrome in intensive care medicine. Intensive Care Med 33:230–236PubMedCrossRef
Metadaten
Titel
Posterior reversible encephalopathy syndrome (PRES): electroencephalographic findings and seizure patterns
verfasst von
Oliver Kastrup
Markus Gerwig
Markus Frings
Hans-Christoph Diener
Publikationsdatum
01.07.2012
Verlag
Springer-Verlag
Erschienen in
Journal of Neurology / Ausgabe 7/2012
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-011-6362-9

Weitere Artikel der Ausgabe 7/2012

Journal of Neurology 7/2012 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.